文献速递生殖医学

精液质量与寿命:对78284名男性随访长达50年的研究

Semen quality and lifespan: a study of 78 284 men followed for up to 50 years.
PubMed 文献 · Hum Reprod · 2025-01-01

该研究纳入1965至2015年间在丹麦哥本哈根地区公共精液分析实验室因夫妇不孕而接受精液质量评估的78284名男性,随访中位23年。所有精液参数均与全因死亡率呈剂量-反应负相关,调整教育水平和既往诊断后估计值未改变。

要点

  • 所有精液参数与全因死亡率呈剂量-反应负相关,P-trend均<0.001。
  • 调整教育水平及精液采样前诊断后,近期亚组死亡风险估计值未改变。

核心结论

  • 所有精液参数与全因死亡率呈明确的负向剂量-反应关联,且该关联不能由教育水平或精液评估时登记的疾病解释。
  • 部分精液质量受损的男性可能经历较不健康的衰老,并可在精液质量评估时被识别而获益。
  • 寻找相关生物标志物以识别风险增高男性亚组,将是启动相关预防策略的关键。

研究设计与样本

  • 基于1965至2015年间在丹麦哥本哈根地区公共精液分析实验室因夫妇不孕接受精液质量评估的78284名男性。
  • 精液质量评估包括精液量、精子浓度、活动精子比例及形态正常精子比例,并据以计算总精子数和总活动精子数。
  • 利用丹麦国家登记系统随访全因死亡率,中位随访23年(5-95百分位:8-45年),期间发生8600例死亡,占总人群11.0%。
  • 近期亚组为1987至2015年间提供精液样本的59657名男性,该时期可获得教育水平和精液采样前疾病信息并在Cox回归中调整。
  • 采用Cox回归分析估计死亡相对差异,以风险比(HR)及95%CI表示。

主要发现

  • 在总人群和近期亚组中,所有精液参数均与死亡率呈剂量-反应负相关(所有精液参数P-trend<0.001)。
  • 在近期亚组中调整教育水平和既往诊断后,估计值未改变。

临床怎么用

  • 原文未据此给出推荐。
  • 作者认为,部分精液质量受损的男性可能经历较不健康的衰老,并可在精液质量评估时被识别而获益。
  • 作者认为,寻找相关生物标志物以识别风险增高男性亚组,将是启动相关预防策略的关键。

局限性

  • 研究未获得健康行为信息。
  • 对精液采样前男性健康状况的评估仅限于从国家患者登记系统获得的诊断,且仅适用于部分男性亚组。
  • 无精子症男性组在睾丸功能方面代表异质性群体,因为无法将其分层为梗阻性无精子症和非梗阻性无精子症。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Is semen quality associated with the lifespan of men? SUMMARY ANSWER: Men with a total motile sperm count of >120 million could expect to live 2.7 years longer than men with total motile sperm count of >0-5 million. WHAT IS KNOWN ALREADY: Male infertility and semen quality have been suggested to be markers of morbidity and thus mortality, but the role of underlying disease present at time of semen quality evaluation has not been thoroughly assessed. The aim of this study was to determine the association between semen quality and mortality, and to assess the impact of the health of the man prior to semen quality assessment. STUDY DESIGN, SIZE, DURATION: The study was based on 78 284 men who had their semen quality assessed between 1965 and 2015 at the public semen analysis laboratory in the Copenhagen area, Denmark, due to reported couple infertility. Thus, the included men covered a wide range of semen quality. Semen quality assessment included semen volume, sperm concentration, and the proportion of motile and morphologically normal sperm, from which the total sperm count and the total motile sperm count were calculated. Utilizing the unique Danish national registers, follow-up of the men regarding all-cause mortality was performed with a median follow-up of 23 years (5-95th percentile: 8-45 years) during which 8600 deaths occurred, accounting for 11.0% of the total population. PARTICIPANTS/MATERIALS, SETTING, METHODS: Life expectancy was calculated according to semen quality. Furthermore, the relative differences in mortality were estimated using Cox regression analyses and presented as hazard ratios (HRs) with 95% CIs. A more recent subpopulation of 59 657 men delivered semen samples between 1987 and 2015, a period in which information on educational level and diseases prior to semen sampling was available and adjusted for in Cox regression analyses. MAIN RESULTS AND THE ROLE OF CHANCE: Men with a total motile count of >120 million could expect to live 80.3 years, compared to 77.6 years among men with total motile count of >0-5 million. In Cox regression analyses, all semen parameters were negatively associated with mortality in a dose-response manner both in the total population and the more recent subpopulation (P-trend for all semen parameters <0.001), and adjustment for educational levels and prior diagnoses did not change the estimates in the latter. Looking at total motile sperm count as an example, men with a total motile sperm count >120 million served as the reference, and the adjusted HRs for all-cause mortality in the more recent subpopulation were: azoospermia: 1.39, >0-5 million: 1.61, >5-10 million: 1.38, >10-40 million: 1.27, >40-80 million: 1.16, >80-120 million: 1.19, P-trend < 0.001. LIMITATIONS, REASONS FOR CAUTION: The study was well-powered and included a unique database of results from semen analyses combined with register follow-up. However, we did not have information on health behaviours, and assessment of the health of men prior to semen sampling was limited to diagnoses obtained from the National Patient Register, and only applied to a subpopulation of men. A further limitation is that the group of men with azoospermia represents a heterogeneous group regarding testicular function as they could not be stratified into those having obstructive azoospermia and those having non-obstructive azoospermia. WIDER IMPLICATIONS OF THE FINDINGS: We observed clear negative dose-response associations between all semen parameters and all-cause mortality. The associations were not explained by educational levels or diseases registered at the time of semen evaluation. Thus, some men with impaired semen quality may experience less healthy ageing than men with better semen quality and could benefit from being identified at the time of semen quality evaluation. However, finding relevant biomarkers to identify the subgroups of men at increased risk will be key to initiating relevant prevention strategies. STUDY FUNDING/COMPETING INTEREST(S): Funding for this study was received from Johan and Hanne Weimann, F. Seedorff's grant (F-24230-01), and the Research Fund of the Capital Region of Denmark (R-153-A6176). None of the funders had any role in the study design, collection, analysis or interpretation of data, writing of the article, or publication decisions. The authors declare they have no competing interests. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Priskorn L, Lindahl-Jacobsen R, Jensen TK, et al. Semen quality and lifespan: a study of 78 284 men followed for up to 50 years. Hum Reprod. 2025. PMID: 40037905. doi:10.1093/humrep/deaf023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。